- Home
- IMTE vs RDHL Comparison
IMTE vs RDHL Comparison
Compare IMTE & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTE
- RDHL
- Stock Information
- Founded
- IMTE 2008
- RDHL 2009
- Country
- IMTE Malaysia
- RDHL Israel
- Employees
- IMTE N/A
- RDHL N/A
- Industry
- IMTE Consumer Electronics/Appliances
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- IMTE Consumer Staples
- RDHL Health Care
- Exchange
- IMTE Nasdaq
- RDHL Nasdaq
- Market Cap
- IMTE 4.1M
- RDHL 3.8M
- IPO Year
- IMTE N/A
- RDHL N/A
- Fundamental
- Price
- IMTE $1.12
- RDHL $1.99
- Analyst Decision
- IMTE
- RDHL
- Analyst Count
- IMTE 0
- RDHL 0
- Target Price
- IMTE N/A
- RDHL N/A
- AVG Volume (30 Days)
- IMTE 9.9K
- RDHL 214.4K
- Earning Date
- IMTE 06-17-2025
- RDHL 04-10-2025
- Dividend Yield
- IMTE N/A
- RDHL N/A
- EPS Growth
- IMTE N/A
- RDHL N/A
- EPS
- IMTE N/A
- RDHL N/A
- Revenue
- IMTE $123,337.00
- RDHL $8,042,999.00
- Revenue This Year
- IMTE N/A
- RDHL $381.91
- Revenue Next Year
- IMTE N/A
- RDHL N/A
- P/E Ratio
- IMTE N/A
- RDHL N/A
- Revenue Growth
- IMTE 4.75
- RDHL 23.17
- 52 Week Low
- IMTE $0.51
- RDHL $1.71
- 52 Week High
- IMTE $3.17
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- IMTE 41.83
- RDHL 51.03
- Support Level
- IMTE $1.05
- RDHL $1.82
- Resistance Level
- IMTE $1.13
- RDHL $1.93
- Average True Range (ATR)
- IMTE 0.04
- RDHL 0.08
- MACD
- IMTE -0.00
- RDHL 0.04
- Stochastic Oscillator
- IMTE 35.00
- RDHL 100.00
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.